Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access maintenance.

Cardiovasc Diagn Ther · 2023 · PMC9971313 · PMID 36864970

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP=0.07so close (0.05 < p ≤ 0.1)

At 6 and 12 months, time to loss of target lesion patency was 153 and 266 days in the DCB group and 142 and 238 days in the control group, respectively, with Kaplan-Meier analysis demonstrating a trend towards improved patency that did not reach statistical significance at 6 months (P=0.07) and converged at 12 months (P=0.37).

also in 111,027 other papers

of borderline significanceno p-value reported

While the degree of LLL was of borderline significance, both access circuit failures (DCB =45 and control =67) and target lesion failures (DCB =33 and control =62) were significantly decreased in the DCB group compared to the control group (P=0.017 and P=0.002, respectively).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.